Dataset Information


Linear and circular CDKN2B-AS1 expression is associated with Inflammatory Bowel Disease and participates in intestinal barrier formation.

ABSTRACT: AIMS:The role of long non-coding RNA's (lncRNA) in the biology of ulcerative colitis (UC) is not well understood. We have previously detected changes in lncRNA's associated with UC. This study aims to characterize one specific lncRNA, CDKN2B-AS1 whose expression was downregulated in UC patients. MAIN METHODS:UC biopsies were used to determine the levels of linear and circular CDKN2B-AS1 relative to healthy controls. In situ hybridization was used to determine the localization of CKDN2B-AS1 in the colon. The intestinal epithelial cell line, Caco-2, was used to study the effects of shRNA mediated loss of CDKN2B-AS1. Transepithelial electrical resistance was used to measure barrier function. An RT-PCR array, immunoblots and immunohistochemistry were used to determine tight junction proteins that CDKN2B-AS1 regulates. KEY FINDINGS:CDKN2B-AS1 is transcribed into not only linear transcripts but also as circular RNA through back-splicing and both forms are decreased in IBD. CDKN2B-AS1 is expressed mainly in colonic epithelial cells. Cells with down-regulated CDKN2B-AS1 exhibited increased proliferation and no alterations in apoptosis. Targeting both the linear and circular transcripts of CDKN2B-AS1 with short hairpin RNAs enhanced barrier function. We subsequently determined that Claudin-2, a "leaky Claudin" known to decrease barrier function, was decreased in CDKN2B-AS1 knockdown cells. SIGNIFICANCE:This study identifies a novel lncRNA with both linear and circular transcripts affecting UC biology.


PROVIDER: S-EPMC6897550 | BioStudies | 2019-01-01

REPOSITORIES: biostudies

Similar Datasets

2019-01-01 | S-EPMC6303254 | BioStudies
2020-01-01 | S-EPMC7184162 | BioStudies
2020-01-01 | S-EPMC7438482 | BioStudies
2021-01-01 | S-EPMC7895987 | BioStudies
2016-01-01 | S-EPMC5076004 | BioStudies
2016-01-01 | S-EPMC4912721 | BioStudies
1000-01-01 | S-EPMC6002690 | BioStudies
2020-01-01 | S-EPMC7564117 | BioStudies
2020-01-01 | S-EPMC7396759 | BioStudies
2016-11-08 | GSE77013 | GEO